Opinion-Editorial
Articles
2009
"Two Simple Ways to Revitalize Seattle
Biotech" Xconomy
February 9,
2009
"Measuring Success in the Biotech
World" Xconomy April 28, 2009
"Forget the Shortcuts: Creating a Truly
Innovative Biotech Culture" Xconomy July 27, 2009
"Why Big Pharma Wants to be Like Big
Biotech" Xconomy August 19, 2009
"Don't Touch My Bags if You Please, Mr.
Customs Man" Xconomy October 5, 2009
"Hollywood Sees Corruption in Pharma, and
Suddenly Scientists are the Bad Guys"
Xconomy
December 7, 2009
“A Brief Year-End Review of Seattle
Biotech” Xconomy December 31,
2009
2010
"The Pharmaceutical R&D Model is Broken.
Here's How to Fix It" Xconomy March 5, 2010
“Biotech’s Second Big Win in Healthcare
Reform: A Tax Credit Bonanza” Xconomy April 8, 2010
“The Bleeding Edge of Pharma: Collaborations, Science, and
Finance” European BioPharmaceutical Review
April 2010
“Biotech’s $1 Billion Tax Credits are Up for
Grabs! OK, Now Everybody Relax” Xconomy May 21, 2010
“Biotech Drug Discovery in Seattle: A Look
Back” Xconomy June 11, 2010
“ZymoGenetics Will Be Missed. How Seattle
Biotech Can Recovery and Thrive” Xconomy September 21,
2010
“The Challenge of Understanding Biotech:
Sifting Through the Fog and Jargon”
Xconomy
October 20, 2010
“The Winners of the IRS Biotech Grant Program
Are ....” Xconomy November 3,
2010
“The Myth of the ‘Patent Cliff’”
Xconomy
November 29, 2010
2011
“What Does Biotech Really Suffer From:
Information Overload, or Underload?”
Xconomy
January 18, 2011
“Advice Received, But Not Taken: Tales from
the Biotech Trenches” Xconomy March 7, 2011
“Who’s Going to Pay for Future Drug
Development?” (Part 1) Xconomy March 22, 2011
“Who’s Going to Pay for Future Drug
Development?” (Part 2) Xconomy March 23, 2011
“Why Do I Love Drug Regulation? Simple: It
Keeps Us Safe” Xconomy April 15, 2011
“Pharma-Academic Alliances: What the Numbers
Don’t Tell You” Xconomy May 10, 2011
“This Drug Didn’t Work for Me. May I Have My
$88,000 Back, Please?” Xconomy June 30, 2011
“Industry Access to the
Literature” Nature Biotechnology
Vol. 29 No.7 pp 571-572, July 2011
“(Mis)Understanding Drug Discovery: It’s Much
Harder Than Rocket Science” Xconomy Sept. 7, 2011
“Biopharma Industry Meetings Could Use Some
Fresh Voices” Xconomy Nov. 1, 2011
Biopharmaceuticals: Nothing Compares to
You Xconomy Nov. 17, 2011
iPubSci: An Alternative to Unaffordable
Science Journals Xconomy Dec. 5, 2011
